9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Estimated reading time: < 1 min

Condition: Advanced Malignant Mesothelioma

Estimated Enrollment: 10

Gender: All

Min Age:

Age Group: Child, Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Assess feasibility of instituting an orientation program, brief follow up care and phone calls in this patient population,  Reduce pre-treatment distress and anxiety,  Improve pre-treatment self-efficacy, Provide educational material delivered by the SRB

Interventions: HIPEC Orientation, Consultation with Survivorship Navigator

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Supportive Care,

Primary Completion Date: April 2011

Completion Date: October 2013

Last  Posted Date: July 3, 2018

Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Website Link: https://ClinicalTrials.gov/show/NCT01126346

Was this article helpful?
Dislike 0